静脉注射的免疫球蛋白对败血症患者的死亡率和炎症状况:一个回顾性数据库研究研究
Hayabusa Takano1,2, Naoki Kanda1,3, Yuji Wakimoto1
1Department of Emergency and Critical Care Medicine, Hitachi General Hospital, Ibaraki, Japan.
Frontiers in immunology
|January 31, 2025
概括
静脉注射免疫球蛋白 (IVIG) 显著降低了败血症患者的死亡率. 这种辅助疗法还改善了实验室标志物和功能状态,可能减轻了败血症引起的免疫抑制.
科学领域:
- 关键护理医学 关键护理医学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 败血症是一种危及生命的感染,静脉注射免疫球蛋白 (IVIG) 作为辅助治疗的有效性存在争议.
- IVIG可以抵消败血症引起的免疫抑制,如持续性炎症,免疫抑制和代谢综合征 (PICS).
研究的目的:
- 评估IVIG作为辅助疗法的有效性,以减少败血症患者的死亡率和改善败血症患者的结果.
主要方法:
- 使用日本住院患者索赔数据库 (2008年4月至2021年9月) 进行的回顾性队列研究.
- 倾向性得分匹配分析比较IVIG和对照组的28天死亡率,住院死亡率,巴特尔指数,住院时间和实验室数据.
主要成果:
- 在匹配的队列中 (758对),IVIG与28天死亡率 (11.9%与16.4%) 和住院死亡率 (18.1%与23.4%) 显著降低.
- 在IVIG组14日和28日观察到白蛋白和C反应蛋白水平的有利结果.
结论:
- IVIG的使用与减少败血症死亡率和改善实验室和功能结果有关.
- 结果表明IVIG有好处,特别是在缓解PICS方面,这需要进一步的前性研究.
相关概念视频
Pneumonia IV: Management
296
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
296
Inflammatory Response II: Inflammatory Exudate and Tissue Repair
4.7K
The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
4.7K
Inflammatory Bowel Disease IV: Pharmacological Management
100
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
100


